Tandem Diabetes Care (TNDM) Enterprise Value (2013 - 2026)
Tandem Diabetes Care's (TNDM) quarterly Enterprise Value came in at -$570.3 million in Q1 2026, down 54.7% YoY from -$1.3 billion in Q1 2025, and down 94.85% on a QoQ basis from -$292.7 million in Q4 2025.
Tandem Diabetes Care (TNDM) Enterprise Value (2013 - 2026) Analysis & Trends
Tandem Diabetes Care (TNDM) has 14 years of Enterprise Value data on file, last reported at -$570.3 million in Q1 2026.
- Quarterly Enterprise Value fell 54.7% year-over-year to -$570.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$570.3 million (down 54.7% YoY) and the FY2025 annual result came in at -$292.7 million, up 33.23% from the prior year.
- Enterprise Value fell to -$570.3 million in Q1 2026, from -$292.7 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$292.7 million in Q4 2025 to a low of -$635.4 million in Q1 2022.
- A 5-year average of -$481.6 million and a median of -$473.3 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2025 — Enterprise Value surged 33.23% — and 2026, when it plunged 54.7%.
- Tracing TNDM's Enterprise Value over 5 years: stood at -$616.9 million in 2022, then climbed by 24.15% to -$467.9 million in 2023, then advanced by 6.32% to -$438.3 million in 2024, then surged by 33.23% to -$292.7 million in 2025, then tumbled by 94.85% to -$570.3 million in 2026.
- The last three Enterprise Value figures came in at -$570.3 million (Q1 2026), -$292.7 million (Q4 2025), and -$319.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Tandem Diabetes Care | 1.57 Bn | 1.11 Bn | 144.78 Mn | -456.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -456.00 Mn |
| Mar 31, 2026 | -570.26 Mn |
| Dec 31, 2025 | -292.67 Mn |
| Sep 30, 2025 | -319.11 Mn |
| Jun 30, 2025 | -315.36 Mn |
| Mar 31, 2025 | -368.63 Mn |
| Dec 31, 2024 | -438.33 Mn |
| Sep 30, 2024 | -473.31 Mn |
| Jun 30, 2024 | -452.42 Mn |
| Mar 31, 2024 | -467.81 Mn |
| Dec 31, 2023 | -467.91 Mn |
| Sep 30, 2023 | -498.16 Mn |
| Jun 30, 2023 | -507.25 Mn |
| Mar 31, 2023 | -519.59 Mn |
| Dec 31, 2022 | -616.90 Mn |
| Sep 30, 2022 | -608.73 Mn |
| Jun 30, 2022 | -635.33 Mn |
| Mar 31, 2022 | -635.39 Mn |
| Dec 31, 2021 | -623.81 Mn |
| Sep 30, 2021 | -594.99 Mn |